GR
Insider selling
Gregory R Friberg sold $177K of Biomarin Pharmaceutical Inc (BMRN) stock
Gregory R Friberg, EVP, Chief R&D Officer of Biomarin Pharmaceutical Inc (BMRN), sold 3,281 shares of BMRN stock worth $177K, per an SEC Form 4 filed May 11, 2026.
It was an open-market sale.
The trade happened on May 7, 2026, 4 days before it was made public.
BMRN has moved +18.4% since the trade date, from $54.12 to $64.06 (Sep 21, 2026 close).
- Traded
- May 7, 2026
- Disclosed
- May 11, 2026
- Filing delay
- 4 days
- Price since
- +18.4%
- Role
- EVP, Chief R&D Officer
- Source
- SEC Form 4
More BMRN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.